- Home
- AQST vs MYPS Comparison
AQST vs MYPS Comparison
Compare AQST & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- MYPS
- Stock Information
- Founded
- AQST 2004
- MYPS 2011
- Country
- AQST United States
- MYPS United States
- Employees
- AQST N/A
- MYPS N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- MYPS EDP Services
- Sector
- AQST Health Care
- MYPS Technology
- Exchange
- AQST Nasdaq
- MYPS Nasdaq
- Market Cap
- AQST 285.4M
- MYPS 229.4M
- IPO Year
- AQST 2018
- MYPS N/A
- Fundamental
- Price
- AQST $3.10
- MYPS $1.77
- Analyst Decision
- AQST Strong Buy
- MYPS Hold
- Analyst Count
- AQST 8
- MYPS 5
- Target Price
- AQST $10.38
- MYPS $3.17
- AVG Volume (30 Days)
- AQST 1.5M
- MYPS 230.2K
- Earning Date
- AQST 03-04-2025
- MYPS 03-10-2025
- Dividend Yield
- AQST N/A
- MYPS N/A
- EPS Growth
- AQST N/A
- MYPS N/A
- EPS
- AQST N/A
- MYPS N/A
- Revenue
- AQST $58,900,000.00
- MYPS $298,759,000.00
- Revenue This Year
- AQST $18.44
- MYPS N/A
- Revenue Next Year
- AQST N/A
- MYPS N/A
- P/E Ratio
- AQST N/A
- MYPS N/A
- Revenue Growth
- AQST 22.56
- MYPS N/A
- 52 Week Low
- AQST $2.24
- MYPS $1.20
- 52 Week High
- AQST $6.23
- MYPS $3.04
- Technical
- Relative Strength Index (RSI)
- AQST 34.77
- MYPS 43.25
- Support Level
- AQST $2.96
- MYPS $1.66
- Resistance Level
- AQST $3.30
- MYPS $1.86
- Average True Range (ATR)
- AQST 0.21
- MYPS 0.10
- MACD
- AQST 0.01
- MYPS -0.02
- Stochastic Oscillator
- AQST 16.87
- MYPS 32.35
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore, and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.